| Residential College | false |
| Status | 已發表Published |
| Noncanonical Regulation of HOIL-1 on Cancer Stemness and Sorafenib Resistance Identifies Pixantrone as A Novel Therapeutic Agent for Hepatocellular Carcinoma | |
Chen, Peng; Dong, Zheyu; Zhu, Wei; Chen, Junling; Zhou, Yuxin; Ye, Qiuyue; Liao, Xinxin; Tan, Yongfa; Li, Chuanjiang; Wang, Yuhao; Pang, Huajin; Wen, Chunhua; Jiang, Yuchuan; Li, Xiaoqing; Li, Bo; Aimaier, Aihetaimu; Lin, Li; Sun, Jian; Hou, Jiajie  ; Tang, Libo; Hou, Jinlin; Li, Yongyin
| |
| 2024-08 | |
| Source Publication | Hepatology
 |
| Indexed By | SCIE |
| Language | 英語English |
| Document Type | Journal article |
| Collection | DEPARTMENT OF BIOMEDICAL SCIENCES |
| Corresponding Author | Hou, Jiajie; Tang, Libo; Hou, Jinlin; Li, Yongyin |
| Recommended Citation GB/T 7714 | Chen, Peng,Dong, Zheyu,Zhu, Wei,et al. Noncanonical Regulation of HOIL-1 on Cancer Stemness and Sorafenib Resistance Identifies Pixantrone as A Novel Therapeutic Agent for Hepatocellular Carcinoma[J]. Hepatology, 2024. |
| APA | Chen, Peng., Dong, Zheyu., Zhu, Wei., Chen, Junling., Zhou, Yuxin., Ye, Qiuyue., Liao, Xinxin., Tan, Yongfa., Li, Chuanjiang., Wang, Yuhao., Pang, Huajin., Wen, Chunhua., Jiang, Yuchuan., Li, Xiaoqing., Li, Bo., Aimaier, Aihetaimu., Lin, Li., Sun, Jian., Hou, Jiajie., ...& Li, Yongyin (2024). Noncanonical Regulation of HOIL-1 on Cancer Stemness and Sorafenib Resistance Identifies Pixantrone as A Novel Therapeutic Agent for Hepatocellular Carcinoma. Hepatology. |
| MLA | Chen, Peng,et al."Noncanonical Regulation of HOIL-1 on Cancer Stemness and Sorafenib Resistance Identifies Pixantrone as A Novel Therapeutic Agent for Hepatocellular Carcinoma".Hepatology (2024). |
| Files in This Item: | There are no files associated with this item. | |||||
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment